Estamos encantados de colaborar una vez más en la 3ra edición del dinámico e innovador “Curso de Donación en Asistolia Controlada Pediátrica y Perfusión de Órganos Ex Situ”, organizado por el equipo pediátrico del Hospital Universitario La Paz e IdiPAZ. Durante los próximos días, los participantes, miembros de diversas especialidades del equipo multidisciplinar tendrán la oportunidad de aprender y practicar técnicas de donación en asistolia controlada y perfusión ex situ hipotérmica oxigenada (HOPE) y normotérmica (NMP); Técnicas innovadoras que están transformando el mundo del trasplante. Con el apoyo de nuestra especialista, Maria Sanchez Mendi, los asistentes podrán descubrir la sencillez y beneficios de la técnica HOPE (Perfusión Hipotérmica Oxigenada) y ponerla en práctica usando el sistema VitaSmart. #Trasplante #PerfusiónDeÓrganos #HospitalLaPaz #IdiPAZ

🌟 HOPE for the Week: Advancing Transplant Preservation Technology A recent study from the Udine transplant center highlights the benefits of using oxygenated hypothermic perfusion machines (MPs) in liver transplants. This innovative method has expanded the donor pool, especially for older donors, while maintaining successful outcomes. Additionally, allowing junior surgeons to work without time pressure, thanks to MP's versatility, has been greatly appreciated. This advancement supports both improved logistics and specialized surgical training. #HOPEfortheWeek #TransplantInnovation #OrganDonation #LiverTransplant

Celebrating One Year in Duluth, Georgia! 🎉 It’s been an incredible year since we opened our doors in Duluth! From fostering innovation to advancing organ preservation solutions worldwide, our team here has made strides that contribute directly to our global mission. Duluth is now home to our onsite R&D lab and new engineering and quality teams, pushing the boundaries of what’s possible in organ preservation. Our progress wouldn’t be possible without the contributions of our other locations, including our Suber team in South Carolina, celebrating 15 years of expanding our customer base and ensuring a steady supply of products. Together, we’re transforming transplant care! Also check out the moment Bridge to Life was awarded the President's ‘E’ Award in Washington, D.C.! This milestone highlights our journey to becoming a global leader in preservation solutions. Cheers to many more years of impact and innovation. 🥂 https://lnkd.in/g9xbsbr8 #1YearInDuluth #Duluth #GlobalPreservationLeader #AnniversaryCelebration

Last week, Bridge to Life attended Asian Transplant Week, connecting with professionals and sharing advancements in transplantation. Events like these inspire innovation and collaboration, driving progress in organ preservation and transplantation worldwide. We are proud to contribute to meaningful discussions that help improve patient outcomes. #BridgeToLife #Transplantation #GlobalCollaboration #AsianTransplantWeek

Great to be back for a few days to the place where my surgical journey started about 40 years ago: Warsaw, Poland 👨🏼⚕️🩺🇵🇱. From 15-16 November, together with prof. dr. Gałązka, Rutger Ploeg, MD PhD FRCS FEBS and Michał Macech I organized the International Masterclass on Donor Management, Kidney Procurement and Preservation in Transplantation at the Medical University of Warsaw - MUW. It were two great days loaded with interesting discussions and hands on practice with kidney perfusion machines. A big thanks to all the participants for their trust and participation in this course. By this means I also want to thank again the Masters for their fantastic contributions and efforts: Frank J.M.F. Dor, MD PhD FEBS(Hon) FRCS Richard Dumbill, MA (Oxon) MBBS MRCS DPhil prof.dr. Zbigniew Gałązka Tadeusz Grochowiecki Sarah Hosgood James Hunter Sijbrand Hofker Volkert Huurman Michał Grąt Maciej Kosieradzki Michał Macech dr. Krzysztof Madej Jolanta Małyszko Sławek Slawomir Nazarewski Nazarek Rutger Ploeg, MD PhD FRCS FEBS dr n. med. Anna Pszenny dr. Tomasz Głogowski Mateusz Zawadka Last but not least, I want to warmly thank our sponsors for not only their contributions but also their trust and big efforts Chiesi Group Astellas Pharma Carnamedica Organ Recovery Systems XVIVO Bridge to Life Ltd. EBERS Aferetica S.r.l.. See you next year in Warsaw!? 😄🇵🇱

This week #BridgetoLife will be at the Medical University of Warsaw for the International Masterclass of Donor Management, Kidney Procurement and Preservation for Transplantation 👉🏻 https://imkpt.com/about/ The #VitaSmart will be part of the hands-on workshop demonstrating the efficacy and simplicity of ❄️ hypothermic oxygenated machine perfusion ❄️

🎉 Bridge to Life Hits Major Milestone! 🎉 We are thrilled to announce that more than 5,000 liver perfusions worldwide have been performed using our Hypothermic Oxygenated Perfusion (HOPE) technology! This milestone highlights our ongoing commitment to advancing organ preservation and improving transplant outcomes. By empowering clinicians to effectively implement HOPE protocols, we are helping to preserve donor livers and enhance patient care around the globe. Here’s to continued innovation and even greater milestones ahead! Read more about this exciting achievement. https://lnkd.in/g8c-sT2Q #BridgeToLife #TransplantInnovation #HOPE #LiverTransplant #OrganDonation #LiverPerfusion

🙌A big thank you 🙌to the German Transplantation Society for hosting a wonderful event in Freiburg, creating a valuable opportunity for the transplant community to exchange knowledge, experiences, and ideas💡. #Transplantation #TransplantCommunity

🌟 HOPE for the Week: Hypothermic Oxygenated Machine Perfusion (HOPE) shows promising results in improving outcomes for high-risk liver transplants from extended criteria donors (ECD) and donation after circulatory death determination (DCDD). A recent meta-analysis of studies comparing HOPE to static cold storage found that HOPE significantly reduces early allograft dysfunction, 12-month graft failure, re-transplantation, and biliary complications—critical areas impacting recovery and long-term success for recipients of high-risk grafts. These findings underscore the potential of HOPE to enhance both patient outcomes and the overall effectiveness of liver transplantation. Further research will help refine these benefits and pave the way for even greater advancements in transplant care. #TransplantInnovation #LiverTransplant #OrganDonation #HOPE

🌟 HOPE for the Week: Innovative Liver Preservation Reduces Costs and Complications in DCD Transplants A new study evaluates the cost-effectiveness of Dual Hypothermic Oxygenated Machine Perfusion (DHOPE) in donation after circulatory death (DCD) liver transplants. Compared to traditional cold storage methods, DHOPE was shown to reduce overall costs by 12% up to one-year post-transplant. ICU and other hospital costs were also significantly reduced. With these advancements, we’re moving closer to optimized transplant care and better resource utilization across the healthcare system. #Transplantation #InnovationInHealth #OrganDonation #HOPE #DCDTransplants